Virpax Pharmaceuticals, Inc.
VRPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $40,417 | $93,699 | $182,124 | $1,004,551 |
| - Cash | $1,513 | $9,142 | $18,995 | $36,842 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $38,904 | $84,557 | $163,129 | $967,709 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12,079,935 | -$14,689 | $0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$12,067,225 | -$15,190 | -$21,456 | -$12,149 |
| % Margin | – | – | – | – |
| EPS Diluted | -2,836.41 | -12.97 | -18.32 | -10.37 |
| % Growth | -21,769% | 29.2% | -76.7% | – |
| Operating Cash Flow | -$16,712,900 | -$9,854 | -$17,847 | -$14,543 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$16,712,900 | -$9,854 | -$17,847 | -$14,543 |